Alerts will be sent to your verified email
Verify EmailORCHPHARMA
Orchid Pharma
|
Guj. Themis Biosyn
|
Gufic Biosciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-4.13 % | 41.95 % | 25.05 % |
5yr average Equity Multiplier
|
1.73 | 1.37 | 2.22 |
5yr Average Asset Turnover Ratio
|
0.45 | 0.89 | 1.05 |
5yr Avg Net Profit Margin
|
-7.02 % | 34.6 % | 10.9 % |
Price to Book
|
2.77 | 14.08 | 5.94 |
P/E
|
35.17 | 71.73 | 51.25 |
5yr Avg Cash Conversion Cycle
|
49.11 Days | -31.8 Days | 26.94 Days |
Inventory Days
|
112.59 Days | 23.52 Days | 66.86 Days |
Days Receivable
|
91.49 Days | 48.29 Days | 128.09 Days |
Days Payable
|
201.52 Days | 135.34 Days | 163.91 Days |
5yr Average Interest Coverage Ratio
|
-0.51 | 187.52 | 13.1 |
5yr Avg ROCE
|
0.51 % | 54.74 % | 27.25 % |
5yr Avg Operating Profit Margin
|
10.69 % | 45.69 % | 18.45 % |
5 yr average Debt to Equity
|
0.49 | 0.05 | 0.51 |
5yr CAGR Net Profit
|
n/a | 20.11 % | 14.26 % |
5yr Average Return on Assets
|
-1.77 % | 30.29 % | 11.52 % |
Shareholdings
|
|||
Promoter Holding
|
69.84 % | 70.86 % | 72.51 % |
Share Pledged by Promoters
|
0.0 | 3.3 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-20.16 % | -4.13 % | -2.97 % |
Change in Mutual Fund Holding (3 Yrs)
|
16.34 % | 1.14 % | 2.36 % |
Orchid Pharma
|
Guj. Themis Biosyn
|
Gufic Biosciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
Asset Break-Up - Geography Wise
|
Asset Break-Up - Geography Wise
|
-
|
-
|